Arnold Lippa
Chief Executive Officer bij RESPIRERX PHARMACEUTICALS INC.
Vermogen: 17 $ op 31-03-2024
Profiel
Arnold S.
Lippa was the founder of Patch International, Inc. (founded in 1984) where he held the title of President & Chief Operating Officer from 1984 to 1994.
He was also the founder of DOV Pharmaceutical, Inc. (founded in 1995) where he served as a Director from 2005 to 2006.
In addition, he is the founder of Atypical BioVentures Fund, LLC (founded in 2004) where he currently holds the title of Manager.
He is also the founder of T.
Morgen Capital LLC (founded in 2005) where he currently holds the title of Senior Managing Director.
Furthermore, he is the founder of Xintria Pharmaceutical Corp.
(founded in 2006) where he currently serves as the Executive Chairman.
Lastly, he is the founder of Atypical BioCapital Management LLC (founded in 2004) where he currently holds the title of Manager.
Dr. Lippa's current job(s) include being the Executive Chairman, President & CEO at RespireRx Pharmaceuticals, Inc. since 2013 and the President of Aurora Capital LLC since 2005.
Dr. Lippa's former job(s) include being a Director-Molecular Neurobiology at Wyeth Holdings LLC, an Independent Director at Hepion Pharmaceuticals, Inc. from 2015 to 2023, and a Professor at City University of New York and New York University School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
27-04-2023 | 7 ( 0.00% ) | 17 $ | 31-03-2024 |
Actieve functies van Arnold Lippa
Bedrijven | Functie | Begin |
---|---|---|
RESPIRERX PHARMACEUTICALS INC. | Chief Executive Officer | 31-01-2022 |
Xintria Pharmaceutical Corp. | Founder | 01-01-2006 |
Aurora Capital LLC
Aurora Capital LLC Investment Banks/BrokersFinance Aurora Capital LLC engages in providing investment banking services. It offers private placement, bridge finance, merger & acquisition, joint venture and technology transfer services. The company was founded in 1994 by Jeff Eliot Margolis and John F. McGovern and is headquartered in New York, NY. | President | - |
Atypical BioCapital Management LLC | Founder | 01-01-2004 |
T. Morgen Capital LLC | Founder | 01-01-2005 |
Atypical BioVentures Fund, LLC | Founder | 01-01-2004 |
Eerdere bekende functies van Arnold Lippa
Bedrijven | Functie | Einde |
---|---|---|
HEPION PHARMACEUTICALS, INC. | Director/Board Member | 22-06-2023 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Chief Executive Officer | 01-01-2006 |
Patch International, Inc.
Patch International, Inc. Contract DrillingIndustrial Services Patch International, Inc. is engaged in the exploration and development of Crude petroleum and natural gas located in the province of Alberta. The company is headquartered in Calgary, Canada. | Founder | 01-01-1994 |
░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
HEPION PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Patch International, Inc.
Patch International, Inc. Contract DrillingIndustrial Services Patch International, Inc. is engaged in the exploration and development of Crude petroleum and natural gas located in the province of Alberta. The company is headquartered in Calgary, Canada. | Industrial Services |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |
Aurora Capital LLC
Aurora Capital LLC Investment Banks/BrokersFinance Aurora Capital LLC engages in providing investment banking services. It offers private placement, bridge finance, merger & acquisition, joint venture and technology transfer services. The company was founded in 1994 by Jeff Eliot Margolis and John F. McGovern and is headquartered in New York, NY. | Finance |
Atypical BioVentures Fund, LLC | |
T. Morgen Capital LLC | |
Xintria Pharmaceutical Corp. | |
Atypical BioCapital Management LLC |